Clairity analyzes speech with artificial intelligence (AI) trained to identify patients at risk of suicide. Designed for mental health professionals whose observations are informed by education, practice, and experience, Clairity provides an additional objective metric to help identify potential risks. Clairity AI identifies vocal biomarkers – noninvasive, objective indicators of mental health states. The vocal biomarkers are tracked over time alongside patient-reported symptoms and clinical impressions. Voice data and clinical impressions are captured by the Clairity app. Standardized patient assessments can be captured in the app or imported securely if they have been captured elsewhere. Clairity returns personalized session summaries, patient-specific treatment progress, and aggregated data to help assess risk across a patient group.

Clarigent Health delivers artificial intelligence and machine learning technology for the early detection of mental health conditions such as distress, suicide ideation, and other types of behavioral health issues. It aims to direct the most appropriate treatment plan for an individual. Clarigent Health was founded in 2018 and is based in Mason, Ohio.

Clairity empowers clinicians with a smart assistant to measure vocal biomarkers. Clairity assigns a risk score based on their voice which is analyzed by our patented, artificial intelligence (AI) model. Clinicians can quickly scan Clairity insights to help inform their diagnosis and treatment decisions.